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A B S T R A C T
Information regarding dietary effects on plasma oxyphytosterol concentrations as well as on the origin of
oxyphytosterols is scarce. We hypothesized that plant sterols are oxidized in the intestinal lumen,
mediated by microbial activity, followed by uptake into the circulation. To address this hypothesis, we
carried out, a randomized, double blind, crossover study in 13 healthy subjects, who consumed for
3 weeks control and plant stanol ester enriched margarines (3.0 g/d plant stanols) separated by a 4-week
wash-out period. Plasma oxy(phyto)sterols were determined via GC–MS/MS, while microbiota analyses
were performed on fecal DNA using a phylogenetic microarray to assess microbial composition and
diversity. Plasma plant sterol concentrations did not correlate with plasma oxyphytosterols
concentrations at baseline. Plant stanol consumption reduced serum sitosterol and campesterol
concentrations (-37% and -38%), respectively (p < 0.001), as well as plasma concentrations of 7b-OH-
campesterol (-24%; p < 0.05), 7b-OH-sitosterol (-17%; p < 0.05) and 7-keto-sitosterol (-13%; p < 0.05).
Although the intestinal microbiota composition and diversity of the faecal contents were not different
between the two periods, we observed signiﬁcant correlations between several speciﬁc bacterial groups
and plasma plant sterol, but not with plasma oxyphytosterol concentrations. In conclusion, plant stanol
ester consumption reduced serum plant sterol and plasma oxyphytosterol concentrations, while
intestinal microbiota composition and diversity were not changed. To deﬁnitely answer the effects of
microbiota on oxyphytosterol formation, future studies could examine oxyphytosterol concentrations
after changing intestinal microbial composition or by measuring intestinal oxyphytosterol formation
after providing labelled non-oxidized plant sterols.
ã 2016 Elsevier Ltd. All rights reserved.
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Cholesterol and plant sterols can be oxidized, which results in
the formation of a variety of different oxycholesterol and
oxyphytosterol metabolites. While oxycholesterol metabolism
and formation has been reviewed extensively [1–3], less is known
about oxyphytosterols in this respect. For example, not much
information is available on the effects of diet on plasma
oxyphytosterol concentrations as well as on the site of oxidation
of plant sterols. Husche et al. reported a signiﬁcant 87% increase in
fasting 7b-OH-sitosterol concentrations in healthy subjects after
consumption of 3.0 g/d plant sterol enriched margarine for 4 weeks
[4]. In contrast, we were not able to show changes in fasting
oxyphytosterol concentrations after plant sterol consumption for
4 weeks despite increased fasting plant sterol concentrations.
However, 7b-OH-campesterol concentrations and – when stan-
dardized for cholesterol – also 7-keto-campesterol concentrations
were decreased after plant stanol consumption [5].
Even though plasma oxyphytosterol concentrations have been
determined in several studies [4–7], the origin of circulating
oxyphytosterols is unclear. Theoretically, plasma oxyphytosterol
concentrations can result from absorption of oxyphytosterols as
present in the diet, from in vivo oxidation of non-oxidized plant
sterols within the circulation and tissues or alternatively, from
oxidation of non-oxidized plant sterols that are present in the
enterocytes or in the intestinal lumen. If circulating oxyphytoster-
ols origin from intestinal oxidation, changes in microbiota
composition could affect oxyphytosterol formation and conse-
quently plasma oxyphytosterol concentrations. This can also
explain the reduction in oxyphytosterol concentrations after plant
stanol consumption, since plant stanol esters not only inhibit
absorption of non-oxidized plant sterols [8] but possibly also that
of oxidized plant sterols [5]. Also our ﬁnding that type II diabeticsFig. 1. Outline of have higher oxyphytosterol concentrations as compared to
controls (unpublished data), combined with the knowledge that
type II diabetics are characterized by modiﬁed microbiota
composition [9] suggests that microbiota might play a role in
oxyphytosterol formation. The intestinal microbiota can regulate
host metabolism at multiple levels and recent studies ascribe a
potential role to the gut microbiota in the development of
metabolic diseases such as obesity, insulin resistance and
cardiovascular diseases (CVD) [10–12]. However, not much is
known on the involvement of intestinal microbiota in cholesterol
metabolism and whether plant sterol or plant stanol consumption
indeed has an effect on the microbiota. In one publication from
1999, it was described that the daily consumption of a plant sterol
enriched margarine did not affect the metabolic activities of the
gut microﬂora [13]. This research was carried out as part of a safety
evaluation of habitual plant sterol use. Since that time, technolo-
gies to assess intestinal microbiota composition and their effects
on host metabolism have improved drastically. Therefore, we
examined in this randomized placebo-controlled trial 1) effects of
plant stanol consumption on plasma oxyphytosterol and oxy-
cholesterol concentrations, 2) effects of plant stanol consumption
on the intestinal microbiota composition and diversity, and 3)
associations between circulating plasma plant sterol/stanol con-
centrations, plasma oxy(phyto)sterol concentrations and micro-
biota characteristics.
2. Subjects and methods
2.1. Subjects, diets and design
Details of the study design and the study population have been
described previously [14,15]. Brieﬂy, subjects were recruited in
Maastricht and surroundings and met the following criteria:study design.
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history of diabetes, cardiovascular or gastrointestinal disorders
and no use of lipid-lowering medication or a (medically)
prescribed diet. In addition, mean serum total cholesterol
concentrations were <7.8 mmol/L, as determined during two
screenings visits. All subjects gave written informed consent
before entering the study. The Medical Ethical Committee of the
Maastricht University Medical Center (MUMC) approved the
protocol and the trial is registered at clinicaltrials.gov as
NCT01574417.
Subjects participated in a randomized placebo-controlled
crossover trial, which consisted of two intervention periods of
3 weeks, separated by a 4-week washout period (Fig. 1) and were
stratiﬁed for age, gender and BMI. Participants were randomly
allocated to start with the control or plant stanol intervention.
Subjects were asked to consume margarine enriched with plant
stanol esters (3 g/day) or control margarine for 3 weeks. For this,
subjects were asked to replace their own spread with the test
margarine (70% fat) of which 20 g had to be consumed on a daily
basis, which provided no, or 3.0 g of plant stanols per day. The
margarines were packed in tubs of 140 g each, providing margarine
for 7 days. The margarines were similar in color and taste and the
tubs were color coded to blind both subjects and investigators. All
volunteers received instructions to consume the margarines
divided over two meals, i.e. at lunch and diner. The margarines
were all rapeseed oil based with saturated soy sterols as source of
the plant stanols, which were provided as fatty acid esters made by
trans esteriﬁcation of free plant stanols with rapeseed oil fatty
acids. Plant stanol mixtures were obtained by saturation of
sitosterol, campesterol and stigmasterol, resulting in sitostanol
ester (76%) and campestanol ester (22%) (Raisio group, Raisio,
Finland).
Subjects visited the university at the start of each 3-week
intervention period and twice at the end of each period. Feces were
collected at the start and end of each intervention period and blood
was sampled on 2 occasions at the end of each period separated by
3 days. After each intervention period, subjects completed a
validated food frequency questionnaire (FFQ) [16], which was
checked by a certiﬁed dietician to calculate energy and nutrient
intakes using the Dutch food composition Table Subjects were
asked not to change their dietary habits, physical activity level and
alcohol intake during the study.
2.2. Blood sampling and feces collection
Blood was sampled in a clotting tube and an EDTA tube (Becton,
Dickinson and Company, Franklin Lakes, NY, USA). Serum was
obtained from the clotting tube by low-speed centrifugation at
1300g for 15 min at room temperature, at least half an hour after
venipuncture and was used for the analysis of lipid, (apo)
lipoprotein and plant sterol, stanol and cholesterol precursor
concentrations. EDTA plasma was obtained by low-speed centri-
fugation at 1300g for 15 min at 4 C and was used for the analysis of
oxysterol and oxyphytosterol concentrations. All serum and
plasma samples were snap frozen in liquid nitrogen and stored
at 80 C until analysis. All samples from one subject were
analyzed with the same analytical run. Fecal samples were
collected in containers and were stored at 80 C until being
analyzed.
2.3. Analyses
2.3.1. Lipid and lipoproteins
Total cholesterol (TCH) (CHOD-PAP method; Roche Diagnostics,
Mannheim, Germany), high-density lipoprotein cholesterol (HDL-
C) (CHOD-PAP method; Roche Diagnostics, Mannheim, Germany)after precipitation of apoB-containing lipoproteins with phospho-
tungstic acid and magnesium ions, and TAG concentrations, with
correction for free glycerol, were analysed in serum enzymatically
(GPO-Trinder; Sigma-Aldrich Corp., St. Louis, MO, USA). Low-
density lipoprotein cholesterol (LDL-C) concentrations were
calculated according to the Friedewald equation [17]. Apolipopro-
tein concentrations (apoA-1 and apoB100) were analysed using
highly sensitive immunoturbidimetric assays (Horiba ABX, Mont-
pellier, France). Lipid and lipoprotein concentrations were
measured in the two samples obtained at the end of each period
and averaged for data analysis.
2.3.2. Plant sterols, plant stanols, non-cholesterol sterols and oxy
(phyto)sterols
Plant sterol (sitosterol, campesterol), plant stanol (sitostanol,
campestanol), cholesterol precursors (lathosterol, desmosterol)
and cholesterol absorption marker (cholestanol) were analyzed by
gas-liquid chromatography-mass spectrometry (GC–MS) as de-
scribed previously [18]. Non-cholesterol sterol concentrations are
expressed as mg/dL. Oxysterols (7a-Hydroxy(OH)-cholesterol, 7b-
OH-cholesterol and 7-keto-cholesterol) and oxyphytosterols (7a-
OH-campesterol, 7a-OH-sitosterol, 7b-OH-campesterol, 7b-OH-
sitosterol, 7-keto-campesterol and 7-keto-sitosterol) were ana-
lyzed by gas chromatography-mass spectrometry (GC–MS-MS)
according a triplequad procedure as before [19]. During work-up
procedures, 5 ml BHT (0.25 mg/mL) per sample was added to avoid
autoxidation. Plant sterol, plant stanol, non-cholesterol sterol and
oxy(phyto) sterol concentrations were measured in the samples
obtained at the end of each intervention periods.
2.3.3. Fecal microbiota
Total DNA from fecal samples was isolated using the repeated
bead beating method as described previously [20]. The Human
Intestinal Tract chip (HITChip), a phylogenetic microarray con-
taining probes for over 1100 known intestinal phylotypes was used
for the semi-quantitative characterization of the fecal microbiota
[21]. Processing of microarray data was performed using a set of R-
based scripts (http://r-project.org) in combination with a custom
designed database under the MySQL database management
system (http://www.mysql.com) as previously described [22].
Bacterial diversity (Shannon index of diversity), including richness
and evenness, was calculated based on the total oligonucleotide
signals.
2.4. Statistics
Endpoint concentrations were compared with a paired t-test to
evaluate the effect of plant stanol ester consumption on lipid,
lipoprotein, plant sterol/stanol and oxy(phyto)sterol concentra-
tions. Endpoint values of microbiota diversity were also evaluated
by a paired t-test and differences between the 130 genus-like
groups included in the HITChip were assessed by Mann-Whitney U
test (Wilcoxon for paired data). Differences at baseline in the
control period in microbiota diversity between males and females
and two BMI categories (25 and >25 kg/m2) were evaluated by
Student’s t-test and differences in microbiota composition were
assessed as described above.
Associations between endpoint concentrations from the control
and plant stanol ester periods in individual plasma oxyphytosterol
concentrations were determined by Pearson product-moment
correlation coefﬁcient. Cross-sectional associations in the control
period between microbiota composition and different sterol/stanol
and oxy(phyto)sterol concentrations and subject characteristics
(BMI and age) were performed by Spearman’s rank correlation
coefﬁcient as implemented in R (version 3.2.0). Correction for
multiple testing was performed by the Benjamin-Hochberg
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presented as means  standard deviations (SD). Results were
considered to be statistically signiﬁcant if p <0.05 and all statistical
analyses were performed using SPSS 20.0 for Mac Os X or higher
(SPSS Inc., Chicago, IL, USA).
3. Results
3.1. Baseline characteristics
Of the initial 18 subjects that completed the study, samples of
13 subjects were available for the analyses described here. Their
baseline characteristics are shown in Table 1. Dietary intakes of
macro- and micronutrients were comparable in both intervention
periods and body weights remained stable throughout the study
(data not shown).
3.2. Serum lipid, lipoprotein and non-cholesterol sterol concentrations
Serum lipid and lipoprotein concentrations are shown in
Table 2. Compared with the control period, serum total cholesterol
concentrations decreased by 7.0% (p < 0.001) and serum LDL-C
concentrations decreased by 9.7% (p < 0.001) after three weeks
plant stanol ester consumption. In line with the effects on serum
LDL cholesterol, serum apolipoprotein B100 concentrations were
decreased by 8.7% (p < 0.01), while no signiﬁcant differences were
found in serum TAG, HDL-C, and apolipoprotein A1 concentrations
after plant stanol consumption as compared with the control
period. After plant stanol consumption, serum sitosterol concen-
trations decreased by 0.12  0.05 mg/dL (-37%; p < 0.01) and
campesterol concentrations decreased by 0.20  0.06 mg/dL
(-38%; p < 0.01) as compared with the control period. In addition,
serum plant stanol concentrations increased after plant stanol
intake, i.e. sitostanol concentrations increased by 33.9.  9.06 mg/
dL (300%; p < 0.01) and campestanol concentrations increased by
13.8  4.8 mg/dL (194%; p < 0.01). Lathosterol and desmosterol
concentrations (surrogate markers of endogenous cholesterol
synthesis) and the cholestanol concentration (marker of choles-
terol absorption) (cholestanol) were not signiﬁcantly different
after 3-week plant stanol ester consumption (Table 2).
3.3. Plasma oxyphytosterol and oxycholesterol concentrations
Table 3 shows plasma oxyphytosterol and oxycholesterol
concentrations after 3 weeks consumption of control and plant
stanol ester enriched margarine. 7a-OH-sitosterol and 7a-OH-
campesterol concentrations were comparable after both interven-
tion periods. Plant stanol consumption reduced 7b-OH-sitosterol
concentrations by 0.18  0.26 (-17%; p < 0.05) and 7b-OH-cam-
pesterol concentrations by 0.13  0.15 (-24%; p < 0.05). Concen-
trations of 7keto-sitosterol were reduced by 1.41 1.82 (-13%;
p < 0.05), while 7keto-campesterol concentrations were not
signiﬁcantly reduced after plant stanol consumption comparedTable 1
Baseline characteristics of the subjects.
Age (years) 30.3  11.6
Male/Female (n) 6/7
BMI (kg/m2) 23.5  2.5
Glucose (mmol/L) 5.2  0.4
Total cholesterol (mmol/L) 5.1  1.2
LDL cholesterol (mmol/L) 3.1  0.9
HDL cholesterol (mmol/L) 1.5  0.4
Triacylglycerol (mmol/L) 1.1  0.4
Values are means  SD (N = 13).with the control period. The sum of the analyzed serum
oxyphytosterol concentrations was signiﬁcantly lowered by 15%
(p < 0.001). Except for reduced 7a-OH-cholesterol concentrations
(-17%; p < 0.01), plant stanol consumption did not change
concentrations of the other oxycholesterol isoforms as compared
with the control period. Serum non-oxidized plant sterol concen-
trations and plasma oxyphytosterol concentrations did not
correlate at baseline (after control intervention) or after plant
stanol consumption. Changes after plant stanol consumption in
individual plasma oxyphytosterol concentrations were signiﬁcant-
ly correlated or tended to correlate with each other (Supplemental
Table 1).
3.4. Fecal microbiota
Fig. 2A presents the relative abundances of microbial phyla at
baseline of the whole group as well as subdivided for gender or for
two BMI categories representing normal weight and overweight
(i.e. 25 and >25 kg/m2 respectively). The largest phyla are
represented by the Firmicutes, followed by Bacteroidetes, Actino-
bacteria and Proteobacteria. The phylum Firmicutes was sub-
divided into Clostridium clusters. Males and females had a
comparable fecal microbiota composition, except for the bacterial
groups related to Clostridium nexile and Klebisiella pneumonia,
which were more abundantly present in females (p < 0.05). The
two BMI categories differed regarding 5 bacterial groups (related to
Atopobium, Bulleidia moorei, Clostridium (sensu stricto), Uncultured
Mollicutes and Weissella.; p < 0.05), which were more abundantly
present in the lower BMI category (25 kg/m2). However,
application of the FDR correction for multiple testing suggested
that the differences observed could also be chance ﬁndings. Fig. 2B
represents the relative abundances of microbial phyla at the end of
the control and plant stanol ester period. There was no change in
fecal microbiota composition after three weeks consumption of
plant stanol compared with the control period in this population of
healthy volunteers. In addition, there were no effects of plant
stanol intake in the composition of the fecal microbiota when the
analyses were repeated for the two BMI or gender groups
separately (data not shown).
Fig. 3A shows the fecal microbiota diversity at baseline
(presented by the Shannon index) in all subjects and separated
for gender and two BMI categories ( 25 and >25 kg/m2). Diversity
was comparable between males and females, and between the two
BMI categories. Fecal microbiota diversity did not change after
consumption of a plant stanol enriched margarine for 3 weeks
compared with the control group (Fig. 3B).
Associations between the 130 genus-like groups identiﬁed in
the HITChip microarray and serum plant sterol/stanol, oxy(phyto)
sterol concentrations and subject characteristics (BMI and age)
generally resulted in high FDR values. Therefore, only signiﬁcant
correlations (p < 0.05 and FDR < 0.3) are reported in Table 4. In
general, serum plant sterol concentrations correlated positively
with a variety of investigated bacterial groups, belonging to the
clostridia (phylum Firmicutes). In addition, negative correlations
were found between serum plant sterol concentrations and
Clostridium colinum and related species. None of the plasma
oxysterol or oxyphytosterol concentrations correlated with any
bacterial groups. For serum plant stanol concentrations, only
serum sitostanol correlated positively with bacterial groups
belonging to the phylum Bacteroidetes and serum campestanol
concentrations correlated negatively with Eubacterium ventriosum
and related species. There were positive correlations identiﬁed
between cholestanol, a surrogate marker for cholesterol absorp-
tion, and several bacterial groups, including those related to
Clostridium cellulosi, Papillibacter cinnamivorans, Outgrouping
Clostridium cluster XIVa and E. ventriosum. Desmosterol
Table 2
Serum lipid, lipoprotein, plant sterol, plant stanol and non-cholesterol sterol concentrations after consumption of control and plant stanol ester enriched
margarines.
Control Plant stanol Change (Stanol—Control)
Total cholesterol (mmol/L) 5.36  0.94 4.98  0.91 0.46  0.41b
LDL cholesterol (mmol/L) 3.17  0.89 2.83  0.75 0.39  0.35b
HDL cholesterol (mmol/L) 1.57  0.32 1.60  0.36 0.03  0.14
Triacylglycerol (mmol/L) 1.32  0.41 1.21  0.48 0.12  0.26
ApoB100 (g/L) 0.93  0.23 0.85  0.21 0.09  0.06a
ApoA1 (g/L) 1.48  0.24 1.47  0.24 0.01  0.11
Sitosterol (mg/dL) 0.32  0.09 0.21  0.07 0.12  0.05a
Campesterol (mg/dL) 0.52  0.14 0.33  0.12 0.20  0.06a
Sitostanol (ug/dL) 11.67  1.78 46.29  9.70 33.90  9.06a
Campestanol (ug/dL) 7.43  1.53 21.62  5.42 13.75  4.82a
Lathosterol (mg/dL) 0.30  0.13 0.30  0.12 0.00  0.08
Cholestanol (mg/dL) 0.51  0.05 0.49  0.06 0.02  0.03
Desmosterol (mg/dL) 0.13  0.04 0.13  0.05 0.00  0.01
Values are means  SD (N = 13).
a p < 0.001.
b p < 0.01.
Table 3
Oxy(phyto)sterol concentrations after consumption of control and plant stanol ester enriched margarines.
Control Stanol Change (Stanol—Control)
7a-OH-sitosterol (ng/mL) 0.42  0.21 0.33  0.12 0.11  0.25
7a-OH-campesterol (ng/mL) 0.36  0.18 0.24  0.08 0.13  0.22
7b-OH-sitosterol (ng/mL) 0.77  0.28 0.59  0.15 0.18  0.26b
7b-OH-campesterol (ng/mL) 0.46  0.16 0.33  0.10 0.13  0.15b
7keto-sitosterol (ng/mL) 8.82  2.70 7.48  1.77 1.41  1.82b
7keto-campesterol (ng/mL) 1.23  0.39 1.00  0.35 0.23  0.52
Sum oxyphytosterols (ng/mL) 12.02  3.39 9.95  2.29 2.18  2.77a
7a-OH-cholesterol (ng/mL) 64.0  26.4 53.0  22.6 12.2  14.3b
7b-OH-cholesterol (ng/mL) 20.6  6.0 18.8  3.5 2.0  5.5
7keto-cholesterol (ng/mL) 22.0  9.21 19.6  2.5 2.9  8.7
24-OH-cholesterol (ng/mL) 31.4  20.2 27.4  7.9 4.3  16.7
27-OH-cholesterol (ng/mL) 45.0  17.3 42.6  16.4 2.5  7.4
Values are means  SD (N = 13).
a p < 0.001.
b p < 0.05.
Fig. 2. No difference in relative abundances of microbial phyla at baseline and after consumption of control or plant stanol ester enriched margarine.
Data is presented for all subjects and for gender and BMI category (BMI I: 25 and BMI II: >25 kg/m2) at baseline (left) and at the end of both intervention periods (right).
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to Streptococcus mitis, but negatively with Uncultured Mollicutes
and Akkermansia. However, no correlations were found with serum
lathosterol (surrogate marker for cholesterol synthesis). Finally,
some bacterial groups correlated positively with age, indicating
that these are more abundantly present with higher age, while BMI
correlated negatively with Uncultured Chroococcales and Uncul-
tured Mollicutes. Indeed, the latter bacterial group was also lessabundantly present in the higher BMI category (p < 0.05, without
FDR correction).
4. Discussion
Absorption rates for plant stanols from the intestinal lumen into
the circulation are very low (<0.5%) and due to rapid clearance
from the circulation by the liver and secretion into bile via hepatic
Fig. 3. No difference in microbiota diversity at baseline in all subjects and after consumption of control or plant stanol ester enriched margarine.
Data is presented for all subjects and for gender and BMI category (BMI I: 25 and BMI II: >25 kg/m2) at baseline (left) and at the end of both intervention periods (right).
Table 4
Associations of bacterial groups at a genus-like level with serum plant sterol/stanol concentrations, BMI and age.
Phylum/Class Genus-like level Variable Correlation coefﬁcient p-value
Actinobacteria
Collinsella Desmosterol 0.483 0.007
Bacteroidetes
Bacteroides splachnicus et rel. Sitostanol 0.507 0.004
Prevotella oralis et rel. Sitostanol 0.559 0.001
Tannerella et rel. Sitostanol 0.534 0.002
Uncultured Bacteroidetes Sitostanol 0.568 0.001
Cyanobacteria
Uncultured Chroococcales BMI 0.483 0.007
Firmicutes
Bacilli Streptococcus mitis et rel. Desmosterol 0.523 0.003
C. cluster IV Clostridium cellulosi et rel. Sitosterol 0.699 0.000
Clostridium cellulosi et rel. Campesterol 0.694 0.000
Clostridium cellulosi et rel. Cholestanol 0.496 0.005
Clostridium leptum et rel. Sitosterol 0.545 0.002
Papillibacter cinnamivorans et rel. Age 0.509 0.004
Papillibacter cinnamivorans et rel. Cholestanol 0.486 0.006
Ruminococcus bromii et rel. Campesterol 0.624 0.000
Ruminococcus bromii et rel. Sitosterol 0.519 0.003
C. cluster XI Anaerovorax odorimutans et rel. Sitosterol 0.507 0.004
Clostridium difﬁcile et rel. Sitosterol 0.529 0.003
C. cluster XIVa Clostridium colinum et rel. Sitosterol 0.550 0.002
Clostridium colinum et rel. Campesterol 0.519 0.003
Clostridium nexile et rel. Desmosterol 0.488 0.006
Coprococcus eutactus et rel. Campesterol 0.491 0.006
Dorea formicigenerans et rel. Campesterol 0.487 0.006
Eubacterium ventriosum et rel. Campestanol 0.506 0.004
Outgrouping clostridium cluster XIVa Cholestanol 0.483 0.007
Ruminococcus lactaris et rel. Campesterol 0.620 0.000
Ruminococcus lactaris et rel. Age 0.516 0.004
C. cluster XVI Eubacterium biforme et rel. Cholestanol 0.549 0.002
Unc. Mollicutes Uncultured Mollicutes Desmosterol 0.529 0.003
Uncultured Mollicutes BMI 0.527 0.003
Verrucomicrobia
Akkermansia Desmosterol 0.742 0.000
Grey shading represent negative correlations (N = 13).
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low and range from 0.002 to 0.012 mg/dL [24,25]. The presence of
plant stanols in the intestinal lumen interferes with intestinal
absorption rates of cholesterol and of plant sterols, which reduces
serum cholesterol and plant sterol concentrations. In the present
study, we observed a reduction of 9.7% in serum LDL-C concen-
trations at a daily intake of 3 g stanol/day, which is in agreement
with a recent meta-analysis estimating an effect of 10.4% (CI:
11.7%; 9.1%) in 11 studies after an average intake of 2.6 g/d ofplant stanols [26]. In addition, serum sitosterol and campesterol
concentrations were reduced by 38%, which is comparable with
observed reductions in previous studies [27]. While the lowering
effect of plant stanols on cholesterol and plant sterol concen-
trations has been observed in many studies, their effect on the
oxidation products of cholesterol and plant sterols, i.e. oxy-
cholesterols and oxyphytosterols have been less extensively
studied. Previously, we demonstrated a decrease of
0.07  0.17 ng/mL (13.6%) in 7b-OH-campesterol in 43 healthy
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4 weeks (3 g/d) [5]. In the current study, we found a stronger
decrease in 7b-OH-campesterol concentrations, i.e. a reduction of
0.13  0.15 (-24%). In addition, other ROS-generated oxyphytos-
terols (7b-OH-sitosterol and 7keto-sitosterol) were also reduced
by plant stanol consumption for 3 weeks and the sum of
oxyphytosterols was decreased with 15%. The same food product
was used in both studies, namely a plant stanol enriched
margarine, providing 3 g of plant stanols per day. In addition,
both studies were performed in a healthy population with a
comparable age range (18–69 years) and lipid proﬁle (TC <6.1
mmol/L). Moreover, the present study evaluated the effect of plant
stanols after 3 weeks, while the previous study had an intervention
period of 4 weeks, but it is unlikely that this difference in duration
can explain why plasma oxyphytosterol concentrations decreased
to a greater extent.
Plant sterol and oxyphytosterol concentrations did not correlate
at baseline and reductions in serum plant sterol concentrations
were also not correlated with changes in plasma oxyphytosterol
concentrations after plant stanol consumption. This is in accor-
dance with previous data, showing that increases in serum plant
sterol concentrations and plasma oxyphytosterol concentrations
also do not correlate. Overall, these data show that neither an
increase nor a decrease in non-oxidized plant sterol concentrations
inﬂuences circulating oxidized plant sterols.
Therefore the question remains where the circulating oxy-
phytosterols come from? Hypothetically, circulating oxyphytos-
terol concentrations can originate from 1) absorption of
oxyphytosterols that are already present in the diet, from 2)
oxidation of non-oxidized plant sterols within the circulation and/
or tissues or from 3) oxidation in the enterocytes and/or intestinal
lumen followed by uptake into the circulation. Previously, we have
postulated that plasma oxyphytosterol concentrations might not
be related to absorption of oxyphytosterols present in the diet,
since a higher dietary intake of oxyphytosterols (0.7 mg vs. 0.1 mg
per day) did not result in higher plasma concentrations after
4 weeks. Furthermore, we were able to show differences in
oxyphytosterol concentrations between subjects with low and
high oxidative stress [28] and between healthy subjects and type
2 diabetic patients (unpublished data). It is unlikely that these
different oxyphytosterol concentrations are attributed to differ-
ences in oxyphytosterol absorption rates. Oxidation of plant sterols
in the circulation and/or tissues might also be a source of plasma
oxyphytosterol concentrations, but in general changes in plasma
plant sterol concentrations after plant sterol or plant stanol
consumption do not correlate with changes in plasma oxy-
phytosterol concentrations [4]. In addition, apoE/ mice that
received daily intraperitoneal injections over 4 weeks with non-
oxidized cholesterol or sitosterol did not show an increase in
plasma oxycholesterol or oxyphytosterol concentrations [29],
implying that substrate oxidation in the circulation might also
not be the most important source of plasma oxyphytosterol
concentrations. As a ﬁnal possibility we postulated that circulating
oxyphytosterols might origin from oxidation of plant sterols within
the enterocyte or in the intestinal lumen. In this context the
microbiota might play a crucial role in the formation of oxy-
phytosterols. For this reason, an objective of this study was to
assess whether a plant stanol-induced decrease in plasma
oxyphytosterol concentrations might be attributed to changes in
intestinal microbiota composition. However, despite reduced
plasma oxyphytosterol concentrations, 3 weeks of plant stanol
consumption did not affect microbiota composition or diversity.
Furthermore, fecal microbiota composition and diversity were
comparable between men and women and between different BMI
categories, and plant stanol consumption did not induce any
changes in these subgroups. In addition, there were nocross-sectional correlations between plasma oxyphytosterol con-
centrations and bacterial groups at genus-like level. Since micro-
biota composition and diversity was not changed after plant stanol
ester consumption, we cannot draw any ﬁrm conclusions related to
the question whether circulating oxyphytosterol concentrations
might origin from intestinal oxidation. For this reason, it would be
highly interesting for future research to assess whether a drastic
change in microbiota composition, for example by an antibiotic
therapy, affects plasma oxyphytosterol concentrations. In addition,
a study where labelled non-oxidized plant sterols are provided and
oxyphytosterol concentrations are measured in luminal content
will also give more information whether oxyphytosterol formation
takes place in the intestinal lumen.
While oxidized plant sterols did not correlate with intestinal
microbiota, there were several cross-sectional correlations be-
tween serum plant stanol/sterol concentrations and bacterial
groups. Serum sitostanol correlated positively with bacterial
groups belonging to the phylum Bacteroidetes, while serum
campestanol concentrations correlated negatively with bacteria
related to E. ventriosum (phylum Firmicutes). E.ventriosum may
produce butyrate, but its abundance has been reported to be higher
in Japanese obese subjects [30] and correlated to polyunsaturated
fatty acids-derived metabolites in Belgian women with metabolic
syndrome [31]. An increase in butyrate-producing bacteria may
affect host energy metabolism by promoting energy harvest [32].
On the other hand, desmosterol (a cholesterol precursor)
correlated negatively with Akkermansia (phylum Verrucomicro-
bia), a bacterium that has been linked to the prevention of obesity
[33]. Although data is inconsistent, a relative higher abundance of
Firmicutes has been associated with obesity and these associations
might indicate potential connections between microbiota compo-
sition and markers of cholesterol metabolism. However, these are
cross-sectional correlations and further evaluation of a potential
involvement of microbiota in cholesterol metabolism would be
interesting to explore into more detail in future research. To our
knowledge, this is the ﬁrst time that plasma plant stanol/sterol
concentrations have been linked to microbiota composition and
further research is warranted in this ﬁeld.
Besides oxidized plant sterols, we also determined oxidized
cholesterol concentrations, namely 7b-OH-cholesterol and 7keto-
cholesterol concentrations (ROS-generated oxycholesterols) and
24-OH-cholesterol and 27-OH-cholesterol concentrations (enzy-
matically-generated oxycholesterols), while 7a-OH-cholesterol
can be produced enzymatically as well as non-enzymatically. Both
24-OH-cholesterol and 27-OH-cholesterol are produced as an
alternative mechanism to secrete cholesterol from brain and
human plaques, respectively [34,35]. Therefore, concentrations of
these oxycholesterols reﬂect a speciﬁc role for these products at a
certain site and any change in cholesterol availability or ROS level
does not inﬂuence their circulating concentrations. It is therefore
not surprising that a change in serum TC concentrations did not
affect 24-OH and 27-OH-cholesterol concentrations. In addition,
also ROS-generated oxycholesterol concentrations were not
changed after plant stanol consumption and changes in cholesterol
and ROS-oxycholesterol concentrations after plant stanol con-
sumption were also not correlated. This is in contrast to plasma
oxyphytosterol concentrations, where 7b-OH- and 7keto-phytos-
terols were reduced after plant stanol consumption. Cholesterol is
present in plasma lipoproteins and in cell membranes. Although
cholesterol can be oxidized, its susceptibility for oxidation is much
lower than polyunsaturated fatty acids that are also present in
lipoproteins and cell membranes [1]. This notion, together with a
modest decrease in serum TC concentrations compared to the large
amount of cholesterol present in the body, most likely explains
why ROS-generated oxycholesterol were not changed after plant
stanol consumption for 3 weeks.
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In conclusion, this study shows that consumption of plant
stanol esters for 3 weeks reduced plasma oxyphytosterol concen-
trations without changing intestinal microbiota composition and
diversity. Further research is needed to provide more insight
whether circulating oxyphytosterol concentrations might be
derived from neutral sterol oxidation in the gastro-intestinal tract.
In this respect, it would be interesting to assess oxyphytosterol
concentrations after changing microbial composition or to provide
labelled non-oxidized plant sterols and to measure oxyphytosterol
concentrations in luminal content.
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